| Older periods | Sep '20 | Dec '20 | Mar '21 | Jun '21 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
233.45% | 211.37% | 233.93% | 189.45% | |
| (24.31%) | (82.81%) | (64.67%) | (65.24%) | ||
ROIC |
(15.65%) | (186.98%) | (149.73%) | (169.29%) | |
Return on Tangible Assets |
(36.49%) | (327.13%) | (147.25%) | (166.91%) | |
Average Days of Receivables |
116.55 | 90.68 | 73.01 | 77.65 | |
Free Cash Flow per Share |
(5.04) | (2.48) | (0.47) | (0.27) | |
Free Cash Flow |
(30.65) | (20.66) | (27.76) | (24.79) | |
Capital Expenditures |
(5.28) | (3.89) | (3.06) | (1.75) | |
Piotroski F-Score |
2.00 | 1.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(15.00%) | (28.38%) | (22.46%) | (23.93%) | |
Accounts Receivable Turnover |
2.79 | 2.86 | 5.38 | 3.96 | |
Accounts Payable Turnover |
5.44 | 6.60 | 8.86 | 7.61 | |
Inventory Turnover |
1.94 | 2.11 | 2.11 | 2.25 | |
Average Days of Payables |
66.95 | 59.35 | 32.47 | 26.15 | |
Days of Inventory on Hand |
204.91 | 174.17 | 143.59 | 112.65 | |
Tax Rate |
0.00 | 0.02 | 0.02 | 0.02 | |
Research and Development Expense of Revenue |
17.70% | 16.94% | 14.84% | 16.60% | |
Selling, General and Administrative Expense of Revenue |
45.44% | 59.62% | 53.72% | 58.99% | |
Share Based Compensation of Revenue |
1.90% | 1.66% | 0.67% | 0.66% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.54 | 0.14 | 0.27 | 0.25 | |
Depreciation/Fixed assets |
0.15 | 0.89 | 0.75 | 0.52 | |
Capex/Depreciation |
(0.36) | (0.27) | (0.26) | (0.21) | |
Revenue per Share |
8.44 | 5.45 | 0.85 | 0.50 | |
Operating CF per Share |
(4.17) | (2.02) | (0.42) | (0.25) | |
Capex per Share |
(0.87) | (0.47) | (0.05) | (0.02) | |
Capex to Sales |
0.10 | 0.09 | 0.06 | 0.04 | |
Net Profit Margin |
(91.50%) | (269.31%) | (188.14%) | (197.78%) |
Columns are period end dates